Effect of the selective estrogen receptor modulator raloxifene on explanted uterine growth in rats
β Scribed by D. Kim Swisher; Robert M. Tague; David E. Seyler
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 282 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Raloxifene i s a selective estrogen receptor modulator known to have antiestrogenic effects o n uterine tissue. In this study, the effects of raloxifene on uterine explant growth were evaluated in rats. Rats were ovariectomized, implanted with an estradiol pellet, and an endometriosis-like state was artificially created by suturing uterine explants near mesenteric blood vessels.
Approximately 21 days after explant surgery, rats with confirmed uterine explant growth were given raloxifene orally at doses of 0 or 10 mgikgiday for 7 or 14 days. After 7 days of raloxifene treatment, explant weight and volume were significantly decreased. Fourteen days of raloxifene treatment, also caused a decrease in explant weight and volume, though not statistically significant. In addition, raloxifene treatment caused weight of the remaining uterine horn to decrease. Histological examination of the explants confirmed the presence of endometrial tissue similar to that seen in the uterus. In this study, raloxifene suppressed explanted uterine growth in a rat model designed to mimic human endometriosis. o 1995 WiIey-Liss, Inc.
π SIMILAR VOLUMES
## Abstract A sensitive LC/MS/MS method has been developed by derivatization of 17Ξ²βestradiol (E2) with dansyl chloride to quantitate 17Ξ²βE2 in female rat serum. The use of E2βd~5~ minimized interferences from endogenous 17Ξ²βE2 in order to achieve a limit of quantitation (LOQ) of 2.5 pg/ml using 15
Sexual differentiation affects various aspects of mammalian liver function. It represents a result of the direct and indirect programming (irreversible) and regulating (reversible) effects of androgens and estrogens and the regulatory actions of other hormonal factors (1-3). The problem of sexual d
Hepatic encephalopathy is ameliorated by drugs acting on the central GABA,-benzodiazepine receptor complex. To investigate whether these effects are specific for hepatic encephalopathy or just reflect a nonspecific aroa~al reaction, various benzodiazepine antagonists like flumazenil or with inverse